Find a Clinical Trial Find out about new research studies 
|
|
|
Relying, in part, on the information that is emerging about the genetic basis of leukemia, investigators are pursuing a variety of strategies to control the disease -- approaches that can kill tumor cells directly, inhibit the body's production of substances that promote their growth, or that enhance the immune response against leukemic cells.
Potential therapies being tested for CML include a new transplantion strategy devised at Memorial Sloan-Kettering, a reinfusion of lymphocytes from the original donor, which may boost CML patients' ability to fight recurrence. The effectiveness of this approach is now under study. Such new approaches are sometimes available to eligible patients through the clinical trial process. For up-to-date details about current clinical trials at Memorial Sloan-Kettering Cancer Center, please visit our clinical trial database.
